CardiaLen's Series B Round

CardiaLen raised a round of funding on March 26, 2015.

CardiaLen develops and commercializes pain-free cardioversion therapy, with a primary focus on atrial fibrillation (AF). The company is developing implantable low-energy (low voltage) pain-free atrial…

Articles about CardiaLen's Series B Round: